» Articles » PMID: 35963851

Elucidation of an MTORC2-PKC-NRF2 Pathway That Sustains the ATF4 Stress Response and Identification of Sirt5 As a Key ATF4 Effector

Overview
Date 2022 Aug 13
PMID 35963851
Authors
Affiliations
Soon will be listed here.
Abstract

Proliferating cancer cells are dependent on glutamine metabolism for survival when challenged with oxidative stresses caused by reactive oxygen species, hypoxia, nutrient deprivation and matrix detachment. ATF4, a key stress responsive transcription factor, is essential for cancer cells to sustain glutamine metabolism when challenged with these various types of stress. While it is well documented how the ATF4 transcript is translated into protein as a stress response, an important question concerns how the ATF4 message levels are sustained to enable cancer cells to survive the challenges of nutrient deprivation and damaging reactive oxygen species. Here, we now identify the pathway in triple negative breast cancer cells that provides a sustained ATF4 response and enables their survival when encountering these challenges. This signaling pathway starts with mTORC2, which upon sensing cellular stresses arising from glutamine deprivation or an acute inhibition of glutamine metabolism, initiates a cascade of events that triggers an increase in ATF4 transcription. Surprisingly, this signaling pathway is not dependent on AKT activation, but rather requires the mTORC2 target, PKC, which activates the transcription factor Nrf2 that then induces ATF4 expression. Additionally, we identify a sirtuin family member, the NAD-dependent de-succinylase Sirt5, as a key transcriptional target for ATF4 that promotes cancer cell survival during metabolic stress. Sirt5 plays fundamental roles in supporting cancer cell metabolism by regulating various enzymatic activities and by protecting an enzyme essential for glutaminolysis, glutaminase C (GAC), from degradation. We demonstrate that ectopic expression of Sirt5 compensates for knockdowns of ATF4 in cells exposed to glutamine deprivation-induced stress. These findings provide important new insights into the signaling cues that lead to sustained ATF4 expression as a general stress-induced regulator of glutamine metabolism, as well as highlight Sirt5 an essential effector of the ATF4 response to metabolic stress.

Citing Articles

Network-Based Bioinformatics Highlights Broad Importance of Human Milk Hyaluronan.

Burge K, Zhong H, Wilson A, Chaaban H Int J Mol Sci. 2024; 25(23).

PMID: 39684390 PMC: 11641400. DOI: 10.3390/ijms252312679.


Targeting sirtuins for cancer therapy: epigenetics modifications and beyond.

Shen H, Qi X, Hu Y, Wang Y, Zhang J, Liu Z Theranostics. 2024; 14(17):6726-6767.

PMID: 39479446 PMC: 11519805. DOI: 10.7150/thno.100667.


Molecular mechanisms and therapeutic strategies for ferroptosis and cuproptosis in ischemic stroke.

Wang J, Lv C, Wei X, Li F Brain Behav Immun Health. 2024; 40:100837.

PMID: 39228970 PMC: 11369453. DOI: 10.1016/j.bbih.2024.100837.


Targeting cellular adaptive responses to glutaminolysis perturbation for cancer therapy.

Kim M, Hwang S, Jeong S Mol Cells. 2024; 47(8):100096.

PMID: 39038517 PMC: 11342766. DOI: 10.1016/j.mocell.2024.100096.


Interplay between mTOR and Purine Metabolism Enzymes and Its Relevant Role in Cancer.

Allegrini S, Camici M, Garcia-Gil M, Pesi R, Tozzi M Int J Mol Sci. 2024; 25(12).

PMID: 38928439 PMC: 11203890. DOI: 10.3390/ijms25126735.


References
1.
Miyamoto N, Izumi H, Miyamoto R, Bin H, Kondo H, Tawara A . Transcriptional regulation of activating transcription factor 4 under oxidative stress in retinal pigment epithelial ARPE-19/HPV-16 cells. Invest Ophthalmol Vis Sci. 2010; 52(3):1226-34. DOI: 10.1167/iovs.10-5775. View

2.
Kazyken D, Magnuson B, Bodur C, Acosta-Jaquez H, Zhang D, Tong X . AMPK directly activates mTORC2 to promote cell survival during acute energetic stress. Sci Signal. 2019; 12(585). PMC: 6935248. DOI: 10.1126/scisignal.aav3249. View

3.
Faubert B, Solmonson A, DeBerardinis R . Metabolic reprogramming and cancer progression. Science. 2020; 368(6487). PMC: 7227780. DOI: 10.1126/science.aaw5473. View

4.
Zhu Y, Yan Y, Principe D, Zou X, Vassilopoulos A, Gius D . SIRT3 and SIRT4 are mitochondrial tumor suppressor proteins that connect mitochondrial metabolism and carcinogenesis. Cancer Metab. 2014; 2:15. PMC: 4203689. DOI: 10.1186/2049-3002-2-15. View

5.
Vicier C, Dieci M, Arnedos M, Delaloge S, Viens P, Andre F . Clinical development of mTOR inhibitors in breast cancer. Breast Cancer Res. 2014; 16(1):203. PMC: 3978635. DOI: 10.1186/bcr3618. View